Search results for " 2018"
Biopharmaceutical Process Development: 2018 Lessons and 2019 Predictions
What might be in store for 2019, and what important lessons should process developers take from 2018? Here, we look back at some of the most popular Process Development Forum articles from 2018 for cl…
Process Development: What May Lie Ahead in 2018?
… Process Development Forum articles from 2017 for insight about what may be heading down the pike in 2018. Continued Growth New drug approvals are on an upward trajectory. While onl…
State of the Biopharmaceutical Industry: Lessons from 2018 Survey Data
What new areas did you explore in this year’s survey? In 2018, and in recent years, we are seeing not just increased interest in and desires for adoption of continuous bioprocessing, but also expe…
DiPIA 2018 Is Just One Month Away!
Don’t miss the DiPIA 2018 conference in Boston, MA. • Be inspired by the latest scientific research. • Engage with leading scientists. • Learn tips and techniques in biophysical characteri…
BioProcessing Asia 2018 Program Now Available
The program for BioProcessing Asia 2018 conference, which will be held at the Langkawi International Convention Centre, 12-15 November, has been released. The program includes keynote talks by…
BioProcessing Asia 2018
The Third International BioProcessing Asia Conference, Langkawi International Convention Centre, Malaysia, November 12-15, 2018.
Annual bioProcessUK Conference 2018
A conference for the manufacturing/biologics community organized by UK BioIndustry Association.
April 17-19: INTERPHEX is pharmaceutical, biotechnology, and medical device development and manufacturing event where you can “Experience Science through Commercialization”.
Fifteen Years of Progress: Biopharmaceutical Industry Survey Results
This article highlights some of the significant changes in biopharmaceutical manufacturing (bioprocessing) that have occurred from 2003 to 2018. Most all of the changes in bioprocessing that have occu…
Biopharma Seeks Balance
To increase the potential for approval, companies need to provide better “packages” that describe how the drug works, said Scott Gottlieb, FDA commissioner, at the 2018 BIO convention in Boston on Jun…